https://www.zacks.com/stock/news/2232652/quest-diagnostics-dgx-new-pact-to-reduce-food-insecurity?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2232652
Feb 27, 2024 - Quest Diagnostics' (DGX) recent collaboration aims to advance food access and healthy eating habits for underserved communities.
zc:-810626733911373088
0
https://www.zacks.com/stock/news/2216443/quest-diagnostics-dgx-advances-in-cancer-research-with-new-deal?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2216443
Jan 26, 2024 - Quest Diagnostics' (DGX) subsidiary Haystack Oncology collaborates with TriSalus Life Sciences to improve therapeutic options for aggressive forms of cancer.
zc:-6297895288763297711
0
https://www.zacks.com/stock/news/2212910/3-discounted-medtech-stocks-poised-for-sturdy-growth-in-2024?cid=CS-ZC-FT-analyst_blog|industry_focus-2212910
Jan 19, 2024 - Prestige Consumer Health (PBH), Quest Diagnostics (DGX) and Hologic (HOLX) are currently at discounted zone that are expected to provide long-term gains.
zc:2737175543120876679
0
https://www.zacks.com/stock/news/2209990/quest-diagnostics-dgx-inks-new-deal-with-ultima-genomics?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2209990
Jan 15, 2024 - Quest Diagnostics' (DGX) new partnership is likely to leverage its oncology expertise and national scale.
zc:5913127828694155687
0
https://www.zacks.com/stock/news/2207650/quest-diagnostics-dgx-to-boost-lab-services-with-new-buyout?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2207650
Jan 09, 2024 - Quest Diagnostics' (DGX) recent acquisition seeks to increase accessibility to cutting-edge, high-caliber and reasonably priced laboratory services.
zc:-1517303758259171151
0
https://www.zacks.com/stock/news/2205238/reasons-to-retain-quest-diagnostics-dgx-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2205238
Jan 03, 2024 - Investors are optimistic about Quest Diagnostics (DGX) on strength in base business and strategic collaborations.
zc:-4611322266330640995
0
https://www.zacks.com/stock/news/2199231/quest-diagnostics-dgx-haystack-oncology-inks-new-deal?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2199231
Dec 18, 2023 - Quest Diagnostics' (DGX) wholly owned subsidiary, Haystack Oncology, partners with the Rutgers Cancer Institute of New Jersey.
zc:-3974252639638099380
0
https://www.zacks.com/stock/news/2195999/beat-the-market-the-zacks-way-shopify-lululemon-telos-in-focus?cid=CS-ZC-FT-analyst_blog|investment_ideas-2195999
Dec 11, 2023 - Our time-tested methodologies were at work to help investors navigate the market well last week. Here are some of our key performance data from the past three months.
zc:-4997743982099694165
0
https://www.zacks.com/stock/news/2195277/quest-diagnostics-dgx-cdc-to-assess-hepatitis-c-burden?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2195277
Dec 08, 2023 - Quest Diagnostics (DGX) and CDC expand research collaboration to better understand the Hepatitis C burden in the United States.
zc:1994028601835838088
0